214 related articles for article (PubMed ID: 23918735)
21. Radiosynthesis of [
Yang L; Brooks AF; Makaravage KJ; Zhang H; Sanford MS; Scott PJH; Shao X
ACS Med Chem Lett; 2018 Dec; 9(12):1274-1279. PubMed ID: 30613339
[TBL] [Abstract][Full Text] [Related]
22. μ and κ opioid receptor distribution in the monogamous titi monkey (Callicebus cupreus): implications for social behavior and endocrine functioning.
Ragen BJ; Freeman SM; Laredo SA; Mendoza SP; Bales KL
Neuroscience; 2015 Apr; 290():421-34. PubMed ID: 25637809
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of [¹⁸F]MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human.
Hostetler ED; Sanabria-Bohórquez S; Eng W; Joshi AD; Patel S; Gibson RE; O'Malley S; Krause SM; Ryan C; Riffel K; Bi S; Okamoto O; Kawamoto H; Ozaki S; Ohta H; de Groot T; Bormans G; Depré M; de Hoon J; De Lepeleire I; Reynders T; Cook JJ; Burns HD; Egan M; Cho W; van Laere K; Hargreaves RJ
Neuroimage; 2013 Mar; 68():1-10. PubMed ID: 23238431
[TBL] [Abstract][Full Text] [Related]
24. Analysis of [3H]bremazocine binding in single and combinatorial opioid receptor knockout mice.
Simonin F; Slowe S; Becker JA; Matthes HW; Filliol D; Chluba J; Kitchen I; Kieffer BL
Eur J Pharmacol; 2001 Mar; 414(2-3):189-95. PubMed ID: 11239918
[TBL] [Abstract][Full Text] [Related]
25. Kappa opioid receptor binding in major depression: A pilot study.
Miller JM; Zanderigo F; Purushothaman PD; DeLorenzo C; Rubin-Falcone H; Ogden RT; Keilp J; Oquendo MA; Nabulsi N; Huang YH; Parsey RV; Carson RE; Mann JJ
Synapse; 2018 Sep; 72(9):e22042. PubMed ID: 29935119
[TBL] [Abstract][Full Text] [Related]
26. Exploring the putative mechanism of allosteric modulations by mixed-action kappa/mu opioid receptor bitopic modulators.
Wang H; Cao D; Gillespie JC; Mendez RE; Selley DE; Liu-Chen LY; Zhang Y
Future Med Chem; 2021 Mar; 13(6):551-573. PubMed ID: 33590767
[TBL] [Abstract][Full Text] [Related]
27. Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain.
Finnema SJ; Stepanov V; Ettrup A; Nakao R; Amini N; Svedberg M; Lehmann C; Hansen M; Knudsen GM; Halldin C
Neuroimage; 2014 Jan; 84():342-53. PubMed ID: 23994452
[TBL] [Abstract][Full Text] [Related]
28. A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM).
Huang Y; Hwang DR; Bae SA; Sudo Y; Guo N; Zhu Z; Narendran R; Laruelle M
Nucl Med Biol; 2004 Jul; 31(5):543-56. PubMed ID: 15219271
[TBL] [Abstract][Full Text] [Related]
29. Design of high affinity cyclic pentapeptide ligands for kappa-opioid receptors.
Przydzial MJ; Pogozheva ID; Ho JC; Bosse KE; Sawyer E; Traynor JR; Mosberg HI
J Pept Res; 2005 Nov; 66(5):255-62. PubMed ID: 16218993
[TBL] [Abstract][Full Text] [Related]
30. Novel fluoroalkyl derivatives of selective kappa opioid receptor antagonist JDTic: Design, synthesis, pharmacology and molecular modeling studies.
Schmitt S; Colloc'h N; Perrio C
Eur J Med Chem; 2015 Jan; 90():742-50. PubMed ID: 25513968
[TBL] [Abstract][Full Text] [Related]
31. Imaging Kappa Opioid Receptors in the Living Brain with Positron Emission Tomography.
Placzek MS
Handb Exp Pharmacol; 2022; 271():547-577. PubMed ID: 34363128
[TBL] [Abstract][Full Text] [Related]
32. Association of in vivo κ-opioid receptor availability and the transdiagnostic dimensional expression of trauma-related psychopathology.
Pietrzak RH; Naganawa M; Huang Y; Corsi-Travali S; Zheng MQ; Stein MB; Henry S; Lim K; Ropchan J; Lin SF; Carson RE; Neumeister A
JAMA Psychiatry; 2014 Nov; 71(11):1262-1271. PubMed ID: 25229257
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and biological evaluation of 14-heteroaromatic-substituted naltrexone derivatives: pharmacological profile switch from mu opioid receptor selectivity to mu/kappa opioid receptor dual selectivity.
Yuan Y; Zaidi SA; Elbegdorj O; Aschenbach LC; Li G; Stevens DL; Scoggins KL; Dewey WL; Selley DE; Zhang Y
J Med Chem; 2013 Nov; 56(22):9156-69. PubMed ID: 24144240
[TBL] [Abstract][Full Text] [Related]
34. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.
Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155
[TBL] [Abstract][Full Text] [Related]
35. In Vivo Evaluation of
Zhou X; Boellaard R; Ishiwata K; Sakata M; Dierckx RAJO; de Jong JR; Nishiyama S; Ohba H; Tsukada H; de Vries EFJ; Elsinga PH
J Nucl Med; 2017 May; 58(5):762-767. PubMed ID: 28062599
[No Abstract] [Full Text] [Related]
36. PET imaging reveals sex differences in kappa opioid receptor availability in humans, in vivo.
Vijay A; Wang S; Worhunsky P; Zheng MQ; Nabulsi N; Ropchan J; Krishnan-Sarin S; Huang Y; Morris ED
Am J Nucl Med Mol Imaging; 2016; 6(4):205-14. PubMed ID: 27648372
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain.
Nabulsi NB; Mercier J; Holden D; Carré S; Najafzadeh S; Vandergeten MC; Lin SF; Deo A; Price N; Wood M; Lara-Jaime T; Montel F; Laruelle M; Carson RE; Hannestad J; Huang Y
J Nucl Med; 2016 May; 57(5):777-84. PubMed ID: 26848175
[TBL] [Abstract][Full Text] [Related]
38. In vivo Characterization of the Opioid Receptor-Binding Profiles of Samidorphan and Naltrexone in Rats: Comparisons at Clinically Relevant Concentrations.
Tan LA; Gajipara N; Sun L; Bacolod M; Zhou Y; Namchuk M; Cunningham JI
Neuropsychiatr Dis Treat; 2022; 18():2497-2506. PubMed ID: 36345421
[TBL] [Abstract][Full Text] [Related]
39. Preclinical Evaluation of
Declercq L; Rombouts F; Koole M; Fierens K; Mariën J; Langlois X; Andrés JI; Schmidt M; Macdonald G; Moechars D; Vanduffel W; Tousseyn T; Vandenberghe R; Van Laere K; Verbruggen A; Bormans G
J Nucl Med; 2017 Jun; 58(6):975-981. PubMed ID: 28232614
[TBL] [Abstract][Full Text] [Related]
40. Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor.
Polepally PR; Huben K; Vardy E; Setola V; Mosier PD; Roth BL; Zjawiony JK
Eur J Med Chem; 2014 Oct; 85():818-29. PubMed ID: 25193297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
